ACADIA Pharmaceuticals Inc.

ACAD

Statistics

$29.97Share Price
$3.7 BMarket Cap
N/AEBIT / EV
N/AFCF / EV
N/AROIC
N/ACash ROIC
9390.9%3yr Avg Revenue Growth
11.12Current Ratio
star logo

Business Model Diligence

We do not yet have Business Model Diligence for this stock.

Statistical Diligence

x mark Cannot calculate EBIT / Enterprise Value, company has negative EBIT.
x mark Cannot calculate Free Cash Flow / Enterprise Value, company has negative Free Cash Flow.
x mark Cannot calculate Return on Invested Capital, company has negative EBIT.
x mark Cannot calculate Cash Return on Invested Capital, company has negative Free Cash Flow.
check mark The 3 Year Average Revenue Growth Value of 9390.9% ranks as Suspicious.
check mark Near-term Financial Health appears to be Very Good. The Current Ratio is 11.12.

Company Description

ACADIA Pharmaceuticals, Inc. engages in the research, development and manufacture of pharmaceutical products. It focuses on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.

Calculations

You must have a MagicDiligence Membership to view the Calculations for this stock. If you are already a member, you need to log in first.